🔴 Moderna Inc is trading 5.7% down today on profit-taking after a cancer vaccine-driven rally

Moderna Inc is trading 5.7% down at $48.65 as the stock consolidates gains following a sharp two-day rally.

• The recent surge was driven by upbeat cancer vaccine data presented with Merck at ASCO 2026, which pushed shares to a high of $51.59 on June 4.
• Broader market weakness is adding downward pressure, with the S&P 500 and Nasdaq Composite falling 1.07% and 1.85% respectively.
• No new negative company-specific announcements have been identified, suggesting the move is a result of profit-taking and macro sentiment.